68 results on '"Enriquez de Salamanca R"'
Search Results
2. Tumour VEGF/Non Tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients
3. Management of hyponatremia associated with acute porphyria-proposal for the use of tolvaptan
4. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells
5. Serum levels of coenzyme Q10 in patients with Alzheimer's disease: Short Communication
6. The genetic basis of porphyria cutanea tarda
7. Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria
8. Serum levels of coenzyme Q 10 in patients with Alzheimer's disease
9. Delta aminolevulinate dehydratase (ALA-D) activity in human and experimental diabetes mellitus
10. Porphyrin-induced protein structural alterations of heme enzymes
11. A Systematic Analysis of the Mutations of the Uroporphyrinogen III Synthase Gene in Congenital Erythropoietic Porphyria
12. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda
13. Effect of multiple doses of volatile anesthetics on heme enzymes
14. Serum levels of coenzyme Q10 in patients with Alzheimer's disease : Short Communication.
15. The genetic basis of porphyria cutanea tarda.
16. Heterogeneity of familial porphyria cutanea tarda.
17. Successful treatment of haemodialysis-related porphyria cutanea tarda with erythropoietin.
18. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria
19. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria
20. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria.
21. Single nucleotide change in the cannabinoid receptor-1 (CNR1) gene in colorectal cancer outcome.
22. Colorectal cancer relapse: allelic alterations associated with tumour marker overexpression.
23. The most frequent HFE allele linked to porphyria cutanea tarda in Mediterraneans is His63Asp.
24. Mechanistic studies on uroporphyrin I-induced photoinactivation of some heme-enzymes.
25. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.
26. Cytosolic and mitochondrial enzymes inactivation by uroporphyrin in light and darkness.
27. A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
28. Absence of circadian variations in urinary porphyrin excretion in normal subjects.
29. Efficiency of three different hemodialysis membranes for plasma porphyrin removal.
30. delta-Aminolevulinic acid dehydratase inactivation by uroporphyrin I in light and darkness.
31. How the atmosphere and the presence of substrate affect the photo and non-photoinactivation of heme enzymes by uroporphyrin I.
32. Salivary porphyrin concentration in porphyria cutanea tarda.
33. Clinical utility of fluorometric scanning of plasma porphyrins for the diagnosis and typing of porphyrias.
34. Administration of the anesthetic isoflurane to mice: a model for acute intermittent porphyria?
35. Porphyrinogenic properties of the anesthetic enflurane.
36. Is hexachlorobenzene human overload related to porphyria cutanea tarda? A speculative hypothesis.
37. Porphyria cutanea tarda associated with HIV infection: are those conditions pathogenetically related or merely coincidental?
38. Desferrioxamine in the treatment of porphyria cutanea tarda: ineffectiveness of intramuscular administration.
39. Significance of adenosine deaminase measurement in sera of patients with HIV-1 infection.
40. Bullous dermatosis of hemodialysis.
41. Association of porphyria cutanea tarda and primary liver cancer: report of ten cases.
42. Electroneurophysiological abnormalities in porphyria cutanea tarda.
43. Treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
44. [Study of liver porphyrins in patients with liver cirrhosis].
45. Hepatitis B serum markers in porphyria cutanea tarda.
46. Hepatic acetylator phenotype in porphyria cutanea tarda.
47. Porphyria cutanea tarda associated with lymphoma.
48. [Porphyrin excretion in normal (author's transl)].
49. [Analysis by infrared spectrometry of renal calculi in whose composition there are porphyrins].
50. [Erythropoietic protoporphyria].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.